Mesenchymal stem cell based regenerative medicine technologies for treatment of radiation induced lesions

New title: Mesenchymal stem cell based regenerative medicine technologies for treatment of radiation induced lesions
Despite current treatments, patients continue to suffer from cutaneous radiation syndrome (CRS) necessitating exploration and implementation of new technologies. Regenerative medicine, by way of adult mesenchymal stem/stromal cell therapy (MSCT), provides novel solutions, which help to improve patients’ quality of life. The main aim of the project is to disseminate and improve adult MSCT, tissue engineering and biobanking technology for treatment of CRS, including experimental research, pre- and clinical studies, in purview of regulatory guidance.